Medical University of Graz
Graz, A-8036, Austria
NCT Number: NCT00407004
This trial compares the efficacy of two artificial liver support systems, MARS (Molecular Adsorbents Recirculating System) and Prometheus (FPSA, Fractionated Plasma Separation and Adsorption), in removing albumin-bound substances such as bilirubin, bile acids, and cytokines.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Graz, A-8036, Austria
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Medical University of Graz
Other
Effect of Extracorporeal Liver Support by MARS and Prometheus on Albumin-Bound Substances in Acute-on-Chronic Liver Failure
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04116242
Acute-On-Chronic Liver Failure, Cirrhosis of the Liver
Basel, Switzerland
View Trial DetailsNCT01254994
Acute-On-Chronic Liver Failure, Blood-Borne Infections
Guangzhou, Guangdong, China
View Trial DetailsNCT05045794
Digestive System Diseases, End Stage Liver Disease
San Bernadino, California, United States
View Trial DetailsNCT01022476
Adenocarcinoma, Blood-Borne Infections
Le Kremlin-Bicêtre, France
View Trial Details